Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2025-03-03

Clinical Trial Update: Study of SSS06 for Chemotherapy-Induced Anemia in Non-Myeloid Malignancies [Phase 2]

View source ↗

Summary

Notes a Phase 2 trial of SSS06 for chemotherapy-induced anemia in non-myeloid malignancies, sponsored by Shenyang Sunshine Pharmaceutical Co., LTD.; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SSS06

Snippet

Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. | Conditions: Chemotherapy-induced Anemia, Non-myeloid Malignancies | Phase 2 | Status: NOT_YET_RECRUITING